Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 01 2019
Historique:
received: 20 10 2017
accepted: 16 11 2018
entrez: 16 1 2019
pubmed: 16 1 2019
medline: 16 4 2020
Statut: epublish

Résumé

There is a large genetic diversity of Plasmodium falciparum strains that infect people causing diverse malaria symptoms. This study was carried out to explore the effect of mixed-strain infections and the extent to which some specific P. falciparum variants are associated with particular malaria symptoms. P. falciparum isolates collected during pharmacovigilance study in Nanoro, Burkina Faso were used to determine allelic variation in two polymorphic antigens of the merozoite surface (msp1 and msp2). Overall, parasite density did not increase with additional strains, suggesting the existence of within-host competition. Parasite density was influenced by msp1 allelic families with highest parasitaemia observed in MAD20 allelic family. However, when in mixed infections with allelic family K1, MAD20 could not grow to the same levels as it would alone, suggesting competitive suppression in these mixed infections. Host age was associated with parasite density. Overall, older patients exhibited lower parasite densities than younger patients, but this effect varied with the genetic composition of the isolates for the msp1 gene. There was no effect of msp1 and msp2 allelic family variation on body temperature. Haemoglobin level was influenced by msp2 family with patients harboring the FC27 allele showing lower haemoglobin level than mono-infected individuals by the 3D7 allele. This study provides evidence that P. falciparum genetic diversity influenced the severity of particular malaria symptoms and supports the existence of within-host competition in genetically diverse P. falciparum.

Identifiants

pubmed: 30644435
doi: 10.1038/s41598-018-36493-y
pii: 10.1038/s41598-018-36493-y
pmc: PMC6333925
doi:

Substances chimiques

Antigens, Protozoan 0
Merozoite Surface Protein 1 0
Protozoan Proteins 0
merozoite surface protein 2, Plasmodium 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

127

Références

Proc Biol Sci. 1999 Apr 7;266(1420):741-8
pubmed: 10331293
Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):799-807
pubmed: 10365405
Trans R Soc Trop Med Hyg. 1999 Feb;93 Suppl 1:59-64
pubmed: 10450428
Tokai J Exp Clin Med. 1998 Dec;23(6):375-81
pubmed: 10622635
Science. 2000 Feb 4;287(5454):845-8
pubmed: 10657296
Science. 2001 May 11;292(5519):1099-102
pubmed: 11352063
J Infect Dis. 2001 Jul 15;184(2):237-41
pubmed: 11424024
Parasitology. 2001 Aug;123(Pt 2):113-23
pubmed: 11510676
Trop Med Int Health. 2001 Aug;6(8):607-13
pubmed: 11555426
Infect Immun. 2003 Feb;71(2):597-604
pubmed: 12540535
Clin Diagn Lab Immunol. 2003 Sep;10(5):973-6
pubmed: 12965937
Trop Med Int Health. 2003 Oct;8(10):857-9
pubmed: 14516295
Parasitology. 2003 Nov;127(Pt 5):411-8
pubmed: 14653530
Malar J. 2004 Sep 14;3:33
pubmed: 15367331
Parasitol Today. 1991 Oct;7(10):277-81
pubmed: 15463389
Int J Parasitol. 2004 Dec;34(13-14):1413-29
pubmed: 15582519
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3200-3
pubmed: 1565611
Trans R Soc Trop Med Hyg. 2005 May;99(5):389-95
pubmed: 15780346
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7624-8
pubmed: 15894623
Infect Genet Evol. 2006 May;6(3):241-8
pubmed: 16112915
Am Nat. 2005 Nov;166(5):531-42
pubmed: 16224719
Am Nat. 2006 Jul;168(1):41-53
pubmed: 16874614
Evolution. 2006 Jul;60(7):1358-71
pubmed: 16929653
Bull Soc Pathol Exot. 2006 Jul;99(3):166-70
pubmed: 16983818
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19914-9
pubmed: 18056635
Ann Trop Med Parasitol. 2008 Mar;102(2):95-102
pubmed: 18318931
Evolution. 2008 Sep;62(9):2359-71
pubmed: 18540947
Travel Med Infect Dis. 2008 Jul;6(4):205-9
pubmed: 18571110
Ann Trop Med Parasitol. 2008 Jul;102(5):377-82
pubmed: 18577328
Parasite Immunol. 2009 Sep;31(9):560-73
pubmed: 19691559
Trop Biomed. 2009 Aug;26(2):165-72
pubmed: 19901903
Ann Trop Med Parasitol. 2010 Jan;104(1):25-33
pubmed: 20149290
Immunol Today. 1991 Mar;12(3):A68-71
pubmed: 2069680
Malar J. 2012 Jul 16;11:232
pubmed: 22799568
Immunol Lett. 1990 Aug;25(1-3):213-6
pubmed: 2283152
Int J Epidemiol. 2012 Oct;41(5):1293-301
pubmed: 23045201
Ecol Lett. 2013 Apr;16(4):556-67
pubmed: 23347009
Parasitol Res. 2013 Apr;112(4):1691-700
pubmed: 23408340
N Am J Med Sci. 2013 Feb;5(2):95-101
pubmed: 23641369
Hum Vaccin Immunother. 2013 Jun;9(6):1241-53
pubmed: 23857274
J Microbiol Immunol Infect. 2015 Apr;48(2):213-8
pubmed: 24681005
Parasite. 2015;22:12
pubmed: 25786326
Lancet. 2015 Jul 4;386(9988):5-7
pubmed: 25913271
Malar J. 2015 Aug 20;14:325
pubmed: 26289949
Proc Biol Sci. 2016 Mar 16;283(1826):20153038
pubmed: 26984625
Proc Biol Sci. 2017 Jul 26;284(1859):null
pubmed: 28747479
Ecol Lett. 2018 Apr;21(4):536-545
pubmed: 29417715
Parasite Immunol. 1986 Nov;8(6):529-39
pubmed: 3543808
Bull World Health Organ. 1966;35(6):873-82
pubmed: 5298036
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3715-9
pubmed: 8170975
Infect Immun. 1996 Jul;64(7):2716-23
pubmed: 8698500
Parasite Immunol. 1997 May;19(5):207-14
pubmed: 9194097
Philos Trans R Soc Lond B Biol Sci. 1997 Sep 29;352(1359):1385-94
pubmed: 9355131
Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):602-5
pubmed: 9463681
Trans R Soc Trop Med Hyg. 1997 Nov-Dec;91(6):719-24
pubmed: 9509189
Parasitology. 1998 Jun;116 ( Pt 6):501-10
pubmed: 9651932
Trans R Soc Trop Med Hyg. 1998 Jan-Feb;92(1):45-9
pubmed: 9692150
Am J Trop Med Hyg. 1998 Nov;59(5):726-35
pubmed: 9840589

Auteurs

Paul Sondo (P)

Institut de Recherche en Sciences de la Santé (IRSS)/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso. paulsondo@yahoo.fr.

Karim Derra (K)

Institut de Recherche en Sciences de la Santé (IRSS)/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Thierry Lefevre (T)

Institut de Recherche en Sciences de la Santé (IRSS)/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.
MIVEGEC, IRD, CNRS, University of Montpellier, Montpellier, France.

Seydou Diallo-Nakanabo (S)

Institut de Recherche en Sciences de la Santé (IRSS)/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Zekiba Tarnagda (Z)

Institut de Recherche en Sciences de la Santé (IRSS)/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Odile Zampa (O)

Centre Muraz of Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso.

Adama Kazienga (A)

Institut de Recherche en Sciences de la Santé (IRSS)/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Innocent Valea (I)

Institut de Recherche en Sciences de la Santé (IRSS)/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.
Centre Muraz of Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso.

Hermann Sorgho (H)

Institut de Recherche en Sciences de la Santé (IRSS)/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Jean-Bosco Ouedraogo (JB)

Institut de Recherche en Sciences de la Santé (IRSS)/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Tinga Robert Guiguemde (TR)

Centre Muraz of Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso.

Halidou Tinto (H)

Institut de Recherche en Sciences de la Santé (IRSS)/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.
Centre Muraz of Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH